Work

Real-world discontinuation and efficacy data of abiraterone acetate/prednisone (AAP) plus androgen deprivation therapy and radiotherapy in localized prostate cancer.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.5_suppl.367

Authors: Fabrizio Di Costanzo, Xue Yan Jiang, John A. Frew, Ian Pedley, Emma Shakespeare, Mariajulia Lagonera, Noor Md Haris, Saira Bashir, Ruth Plummer, Alastair Greystoke, Christoph Oing, Luigi Formisano, Pasquale Rescigno, Robert Chandler

Institutions: University of Naples Federico II, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne Hospital, Sir Bobby Robson Foundation, Newcastle University, Freeman Hospital

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407698598

Cites:

Cited by: 2

Related to: 10